Inventor · disambiguated record
Juan Luengo
Also filed as: LUENGO JUAN · LUENGO JUAN I · LUENGO JUAN IGNACIO
58 granted patents·15 pending applications·697 citations·filing 1993–2024
98Inventor score
Files withSMITHKLINE BEECHAM CORP35PRELUDE THERAPEUTICS INC16QUANTA THERAPEUTICS INC6GLAXOSMITHKLINE LLC4GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD2
Top patents by PatentIndex Score
73 records- 0196US7160870B2Thrombopoietin mimeticsGLAXO GROUP LTD·Filed 2001·Granted Jan 9, 2007·80 cites·22 claims
- 0294US11254683B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Granted Feb 22, 2022·3 cites·35 claims
- 0394US11214574B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Granted Jan 4, 2022·3 cites·16 claims
- 0493US7332481B2Thrombopoietin mimeticsSMITHKLINE BEECHAM CORP·Filed 2007·Granted Feb 19, 2008·20 cites·26 claims
- 0591US10570140B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2018·Granted Feb 25, 2020·4 cites·29 claims
- 0691US7335649B2Thrombopoietin mimeticsSMITHKLINE BEECHAM CORP·Filed 2006·Granted Feb 26, 2008·12 cites·33 claims
- 0790US10711007B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2019·Granted Jul 14, 2020·6 cites·26 claims
- 0889US6720345B1Semicarbazone derivatives and their use as thrombopoietin mimeticsSMITHKLINE BEECHAM CORP·Filed 2000·Granted Apr 13, 2004·24 cites·11 claims
- 0989US6552008B1Thrombopoietin mimeticsSMITHKLINE BEECHAM CORP·Filed 2000·Granted Apr 22, 2003·59 cites·14 claims
- 1088US9505745B2Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2014·Granted Nov 29, 2016·11 cites·20 claims
- 1188US7790704B2Thrombopoietin mimeticsGLAXOSMITHKLINE LLC·Filed 2008·Granted Sep 7, 2010·6 cites·10 claims
- 1288US6642265B1Thrombopoietin mimeticsSMITHKLINE BEECHAM CORP·Filed 2000·Granted Nov 4, 2003·26 cites·16 claims
- 1387US11912723B2KRAS modulators and uses thereofQUANTA THERAPEUTICS INC·Filed 2023·Granted Feb 27, 2024·1 cites·39 claims
- 1487US6858630B2Naphthimidazole derivatives and their use as thrombopoietin mimeticsSMITHKLINE BEECHAM CORP·Filed 2000·Granted Feb 22, 2005·23 cites·12 claims
- 1586US7674887B2Thrombopoietin mimeticsGLAXOSMITHKLINE LLC·Filed 2008·Granted Mar 9, 2010·5 cites·4 claims
- 1685US11208416B2Selective inhibitors of protein arginine methytransterase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Granted Dec 28, 2021·1 cites·37 claims
- 1784US6875786B2Thrombopoietin mimeticsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Apr 5, 2005·14 cites·10 claims
- 1883US7473686B2Thrombopoietin mimeticsSMITHKLINE BEECHAM CORP·Filed 2007·Granted Jan 6, 2009·3 cites·25 claims
- 1983US5981551A2,5-diimino-3a,6a-diaryl-1,2,3,3a,4,5,6,6a-octahydroimidazo[4,5-d]imidazoles which are effective as G-CSF mimeticsSMITHKLINE BEECHAM CORP·Filed 1997·Granted Nov 9, 1999·45 cites·14 claims
- 2082US6413952B1Agonizing dimeric cell-surface receptors with a receptor binding moiety and chelating metalSMITHKLINE BEECHAM CORP·Filed 1999·Granted Jul 2, 2002·54 cites·3 claims
- 2182US6280959B1Metal complexesSMITHKLINE BEECHAM CORP·Filed 1998·Granted Aug 28, 2001·48 cites·53 claims
- 2280US7452874B2Thrombopoietin mimeticsSMITHKLINE BEECHAM CORP·Filed 2007·Granted Nov 18, 2008·2 cites·18 claims
- 2380US6482956B2Endothelin receptor antagonistsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Nov 19, 2002·8 cites·1 claims
- 2480US5362735ARapamycin derivativesSMITHKLINE BEECHAM CORP·Filed 1994·Granted Nov 8, 1994·37 cites·18 claims
- 2579US8778937B2Benzimidazole boronic acid derivatives as PI3 kinase inhibitorsGLAXOSMITHKLINE LLC·Filed 2012·Granted Jul 15, 2014·2 cites·9 claims
- 2678US9790212B2Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2016·Granted Oct 17, 2017·2 cites·20 claims
- 2776USRE37421ERapamycin derivativesSMITHKLINE BEECHAM CORP·Filed 1993·Granted Oct 23, 2001·16 cites·20 claims
- 2874US12421254B2KRAS modulators and uses thereofQUANTA THERAPEUTICS INC·Filed 2024·Granted Sep 23, 2025·0 cites·17 claims
- 2973US2022153747A1Selective Inhibitors Of Protein Arginine Methytransterase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3072US12459950B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2022·Granted Nov 4, 2025·0 cites·20 claims
- 3172US2025243222A1Pyrimidine based modulators and uses thereofQUANTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3271US12145947B2Pyrimidine based modulators and uses thereofQUANTA THERAPEUTICS INC·Filed 2023·Granted Nov 19, 2024·0 cites·22 claims
- 3371US2025042921A1Kras modulators and uses thereofQUANTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3469US11078205B2Selective inhibitors of protein arginine methlytransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Granted Aug 3, 2021·0 cites·26 claims
- 3568US10975056B2Substituted pyridines as inhibitors of DNMT1GLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Apr 13, 2021·1 cites·21 claims
- 3668US7648971B2Thrombopoietin mimeticsSMITHKLINE BEECHAM CORP·Filed 2008·Granted Jan 19, 2010·0 cites·18 claims
- 3768US5648361ARapamycin derivativesSMITHKLINE BEECHAM CORP·Filed 1993·Granted Jul 15, 1997·22 cites·18 claims
- 3867US6498155B1Methods of treating thrombocytopeniaSMITHKLINE BEECHAM CORP·Filed 1999·Granted Dec 24, 2002·29 cites·12 claims
- 3967US2023174539A1Substituted Pyrrolo[2,3-D]Pyrimidines As Inhibitors Of Protein Arginine Methyl Transferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4066US9096605B2Pyrazolopyrimidine derivatives as PI3 kinase inhibitorsLIN HONG·Filed 2012·Granted Aug 4, 2015·1 cites·2 claims
- 4165US7439342B2Thrombopoietin mimeticsSMITHKLINE BEECHAM CORP·Filed 2007·Granted Oct 21, 2008·0 cites·11 claims
- 4264US2023010358A1Spiro-Sulfonamide Derivatives As Inhibitors Of Myeloid Cell Leukemia-1 (MCL-1) ProteinPRELUDE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4363US11130769B2Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (MCL-1) proteinPRELUDE THERAPEUTICS INC·Filed 2019·Granted Sep 28, 2021·0 cites·31 claims
- 4463US2024327356A1Pyrimidine based ras modulators and uses thereofQUANTA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4561US7241783B2Thrombopoietin mimeticsLIGAND PHARMACEUTICAL·Filed 2001·Granted Jul 10, 2007·1 cites·1 claims
- 4660US11524962B2Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein arginine methyl transferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2018·Granted Dec 13, 2022·0 cites·23 claims
- 4760US6670387B1Thrombopoietin mimeticsSMITHKLINE BEECHAM CORP·Filed 1999·Granted Dec 30, 2003·23 cites·15 claims
- 4856US5661156ARapamycin derivativesSMITHKLINE BEECHAM CORP·Filed 1993·Granted Aug 26, 1997·11 cites·17 claims
- 4956US2013078213A1Thrombopoietin mimeticsDUFFY KEVIN J·Filed 2012·Application pending·0 cites
- 5055US6030970AEndothelin receptor antagonistsSMITHKLINE BEECHAM CORP·Filed 1996·Granted Feb 29, 2000·6 cites·13 claims
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Juan Luengo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →